SynthesisBMC endocrine disorders2026
The association of dietary polyphenols with obesity: a systematic review and meta-analysis.
Synthesis in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimAccumulating evidence has proposed that dietary polyphenols may be linked to lower odds of obesity; nevertheless, the results are inconclusive. This meta-analysis was performed to examine the relationship between dietary intake of polyphenols and the odds of obesity.
methodsA systematic literature search in PubMed, Web of Science, and Scopus was conducted up to April 2025 to obtain all eligible studies. Odds ratios (OR) and 95% confidence intervals (95%CI) were pooled using the random effects model to test the odds of obesity (assessed by body mass index) for the highest versus the lowest intakes of total, subclasses and individual polyphenols.
resultsA total of 3,113 studies were retrieved, of which 3,103 unrelated studies were excluded. Finally, 10 studies with 106,302 participants were included in the meta-analysis. When different polyphenolic compounds were pooled, they were linked to lower odds of obesity (OR: 0.91; 95%CI: 0.85–0.97), with significant evidence of heterogeneity (I2 = 84.0%, P < 0.001). The association was not modified by the age of participants. Higher intakes of total flavonoids (OR: 0.77; 95%CI: 0.64–0.92) and isoflavones (OR: 0.93; 95%CI: 0.88–0.98) were also significantly linked to the reduced odds of obesity. Moreover, a higher intake of flavonols was protective against obesity in some subgroups. No significant association was found for flavones, flavanones, flavanols, and anthocyanins. In the dose-response meta-analysis, the association of total flavonoids with obesity did not follow a linear (P = 0.18) or non-linear (P nonlinearity = 0.18) pattern.
conclusionThe findings of this meta-analysis revealed that higher polyphenol intake is associated with decreased odds of obesity. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.